Antengene Corporation announced the appointment of Thomas Karalis as Head of Asia Pacific Regions. In this position, Tom will be responsible for the commercialization of Antengene products in Australia, New Zealand, S. Korea, Taiwan, Hong Kong and ASEAN regions and will report directly to John Chin, Chief Business Officer of Antengene.
Prior to this role, Tom was the General Manager for Celgene East Asia and Vice President & General Manager for Celgene Australia and New Zealand, where he made outstanding accomplishments in general management and commercial strategies.
Tom is a seasoned industry leader with over 30 years of experience working at several multinational biopharmaceutical companies in Australia and across multiple Asia Pacific countries/regions.
Prior to Celgene, he served as General Manager for Abbott Nutrition (Philippines), BMS (Thailand, Vietnam, Singapore), and held senior positions at Eli Lilly (South Korea) and Pharmacia.
Dr. Jay Mei, Chairman and CEO of Antengene, said, “We are glad that Tom is joining the Antengene team and with his proven successful track record as a Commercial Leader, Tom will further strengthen our ability to deliver meaningful results and grow our footprint in Australia and the other countries/regions now and into the future.”
John Chin, Chief Business Officer of Antengene, said, “I am confident that Tom, a seasoned industry leader with a proven track record, will accelerate the growth of a world-class commercial team for Antengene and bring value to cancer patients across the region.”
“I am delighted to be joining Antengene at this exciting time. Dr. Jay Mei has built an impressive company with a talented team that is rapidly developing an innovative portfolio of cancer therapies. I am looking forward to working with Jay, John and the entire Antengene team to commercialize our portfolio and fulfill our mission of treating patients beyond borders as we build an industry leading cancer company.” said Thomas Karalis.
Antengene is a China-and-U.S. based biopharmaceutical company focusing on drug discovery, clinical development and the commercialization of innovative therapeutics to meet unmet medical needs.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.